FDA Grants Accelerated Approval To Zanidatamab-Hrii For Adult Patients With Previously Treated, Unresectable Or Metastatic HER2-Positive Biliary Tract Cancer
- November 21, 2024
You must be logged in to access this content.
Health Law Daily
This site uses cookies to store information on your computer. Without consent certain enhanced features will not be available and future visits may require repeated consent, so it is recommended to accept the use of cookies. Visit the AHLA Privacy Policy for more information.
You must be logged in to access this content.